Scientists have discovered a new form of brain plaque, termed “mitochondrial plaques,” that could transform current understanding of Alzheimer’s disease. Researchers at the University of Minnesota uncovered this feature in both preclinical disease models and human brain tissue. Their findings, shared in Nature Neuroscience, highlight that these plaques might appear before the widely studied beta-amyloid […]
The discussion surrounding peptides has expanded significantly, especially after a marathon hearing by a panel advising the Food and Drug Administration (FDA). During this session, a focus was placed on seven peptide therapies. Despite FDA scientists voicing concerns, the panel supported all but one therapy. These peptides, like BPC-157, TB-500, and MOTS-c, are in demand. […]
A study by the American Academy of Neurology indicates a link between reduced sugar intake before age two and a 23% decrease in the risk of developing dementia later in life. Dr. Marc Siegel, a Fox News medical analyst, emphasizes this finding while also warning of rising caffeine consumption among young people. Common caffeine sources […]
According to a new study, women with a family history of breast cancer may still have a greater risk of developing the disease, even if they test negative for gene mutations. BRCA1 and BRCA2 gene testing is often recommended for women with a personal or family history of cancers. The American Cancer Society indicates that […]
A recent study published in the journal npj Aging suggests that reducing sugar intake during the first 1,000 days after conception may significantly lower the risk of developing Alzheimer’s disease later in life. The research indicates that individuals exposed to sugar restriction from pregnancy until about age 2 had a 46% lower chance of developing […]
Millions of older adults under Medicare prescription drug coverage could face higher monthly costs in 2027. The Trump administration plans to conclude a temporary subsidy program that has helped reduce premiums for two years. The Centers for Medicare & Medicaid Services (CMS) announced the end of the subsidy this week. This program was initially introduced […]
A new discovery in blood proteins could be a significant advancement in the fight against amyotrophic lateral sclerosis (ALS). Researchers have identified proteins that show changes months or even years before symptoms of this neurodegenerative disease surface, potentially allowing for earlier intervention to prevent nerve damage. About ALS ALS, known as Lou Gehrig’s disease, affects […]
New research highlights an overlooked condition that could indicate a higher risk for developing dementia years before symptoms appear. This study identifies frailty—a condition marked by reduced physical resilience and increased vulnerability to illness—as linked to earlier dementia onset. The findings, published in the Journal of Neurology, Neurosurgery & Psychiatry, examined data from 1,614 older […]
Researchers have made strides in understanding why Alzheimer’s disease progresses to dementia in some people, but not in others. A study from teams in Belgium and the UK sheds light on the role of brain immune cells. Their findings, published in Nature Medicine, indicate a significant role of microglia in the disease’s progression. Role of […]
A panel from the Food and Drug Administration (FDA) with connections to the industry recommended easing regulations on six peptides. This decision was made despite objections from FDA scientists who cited insufficient data. Peptides are touted for benefits like faster healing, improved skin appearance, and extended lifespan, though evidence supporting their effectiveness and safety is […]